Please Wait.....
Report
Middle East Diabetes Devices and Therapeutics Market Investment Opportunities - Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape - Q2 2025 Update
Market Report I 2025-03-28 I 260 Pages I BioIntel360
According to BioIntel360, diabetes market in Middle East is expected to grow by 9.2% on annual basis to reach US$5,455.8 million in 2025.
The diabetes market in the region has experienced robust growth during 2020-2024, achieving a CAGR of 9.9%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.6% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 4,996.5 million to approximately USD 7,960.8 million.
Key Trends and Drivers in the Middle East
The Middle Eastern diabetes devices and therapeutics market is being shaped by national diabetes screening initiatives, integration of digital health tools, regional manufacturing investments, and expanding public-private partnerships. These trends are expected to intensify over the next 2-4 years, leading to improved patient identification, technology-driven care delivery, and more competitive regional production capacity.
Strengthen National Diabetes Screening Programs
- Countries such as Saudi Arabia, the UAE, and Qatar are expanding diabetes screening programs under national health strategies. The UAE's "Weqaya" and Saudi Arabia's Vision 2030 have included routine screening for diabetes and other NCDs.
- Rising diabetes prevalence, particularly Type 2, has driven governments to prioritize early detection. National registries and workplace wellness screenings are key enablers.
- These efforts are expected to expand further, increasing demand for point-of-care HbA1c and glucose testing equipment. Broader detection will also drive downstream growth in therapeutic and monitoring solutions.
Deploy Digital Tools for Personalized and Remote Care
- Mobile apps, cloud-based data platforms, and remote monitoring tools are being integrated into diabetes management programs. Countries like the UAE and Bahrain have deployed app-based platforms for diabetes tracking and patient engagement.
- Government investments in digital health infrastructure, along with private sector innovation from firms such as GluCare.Health (UAE), are key drivers.
- Over the next 2-4 years, the use of digital tools is expected to increase, improving glycemic control, especially for tech-enabled urban populations.
Expand Regional Manufacturing of Insulin and Devices
- Saudi Arabia and the UAE are investing in local production of diabetes therapeutics, including insulin and oral antidiabetics. The King Abdullah Economic City has attracted pharmaceutical manufacturers under the National Industrial Development Program (NIDLP).
- Supply chain disruptions, cost-control efforts, and localization mandates are prompting countries to reduce dependence on imports.
- These investments are expected to grow, supported by long-term industrial strategies and increasing regulatory incentives for regional self-sufficiency in health manufacturing.
Enhance Access Through Public-Private Partnerships
- Governments are collaborating with multinational pharma and MedTech firms to expand access to diabetes devices and therapies. In 2023, the UAE and Saudi Arabia launched partnership programs with companies like Novo Nordisk and Abbott to expand access to CGMs and insulin analogs.
- Health system transformation programs, such as Saudi's Health Sector Transformation Program and UAE's federal health funding reforms, are creating room for innovative care delivery models.
- These partnerships will likely intensify, leading to greater availability of advanced solutions, particularly in public health settings.
Competitive Landscape in the Middle East
The Middle Eastern diabetes devices and therapeutics market is a mix of multinational leadership, growing regional players, and public-private alliances. Ongoing localization efforts and digital innovation are reshaping the competitive environment, with increased consolidation and regional supply chain integration expected in the coming years.
Current Market Conditions
- The region has high diabetes prevalence rates-particularly in the GCC-driving steady demand for CGM devices, insulin therapies, and oral antidiabetics.
- Public sector funding dominates diabetes care, with private insurers playing a growing role in urban and expat populations.
Key Players and New Entrants
- Global companies like Novo Nordisk, Sanofi, Medtronic, and Abbott are established in the region through distribution partnerships and regional hubs.
- Regional companies such as SPIMACO (Saudi Arabia) and Julphar (UAE) are producing generic antidiabetics and distributing SMBG devices.
- Emerging players in digital health, including GluCare.Health and Altibbi, are introducing AI-based diabetes monitoring and lifestyle management tools.
Recent Partnerships, Mergers, and Acquisitions
- In 2023, Novo Nordisk signed a strategic agreement with the UAE Ministry of Health to support national diabetes programs and access initiatives.
- Medtronic expanded its presence in Saudi Arabia through a local partnership with Tamer Group to distribute insulin pumps and CGM systems.
- Julphar restructured its diabetes portfolio to include biosimilar insulin under licensing agreements with international players.
Forecast Competitive Dynamics (Next 2-4 Years)
- Multinationals are expected to deepen regional presence through joint ventures and manufacturing tie-ups.
- Regional firms will expand scale and scope, especially as governments enforce localization targets and industrial strategy milestones.
- Digital health firms will capture new patient segments, driving differentiation based on AI-enabled services and remote care integration.
This report provides a detailed data-centric analysis of the diabetes industry in Middle East, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.
BioIntel360's research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.
This title from BioIntel360 is a bundled offering, combining the following 4 reports, covering 160 tables and 216 figures:
1. Middle East Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
2. Israel Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
3. Saudi Arabia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
4. United Arab Emirates Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
This title from BioIntel360 is a bundled offering, combining the following 4 reports, covering 160 tables and 216 figures:
Regional Report - Middle East Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 1 - Israel Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 2 - Saudi Arabia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 3 - United Arab Emirates Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
All global, regional, and country reports mentioned above will have the following tables of contents:
1 About this Report
1.1 Research Methodology
1.2 Disclaimer
2 Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
3 Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
4 Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
5 Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
5.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
6 Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
7 Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
7.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
8 Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
9 Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
9.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
9.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
10 Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
11 Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
12 Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
12.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
13 Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
14 Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
15 Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
15.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
15.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
15.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
16 Further Reading
16.1 About BioIntel360
16.2 Related Research
16.3 Consulting
This bundled offering has 40 tables across 4 regional and country reports. All regional and country reports will have the following tables:
Table 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
This bundled offering has 53 figures across 4 regional and country reports. All regional and country reports will have the following figures:
Figure 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security